CIK 0001430306
- Non-accelerated filer
- Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261434750
- Phone
- +1 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.49 ($12,440)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $2.38 ($59,375)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 500 shares at $4.64 ($2,320)
- 4 Open-market buy Chief Executive Officer bought 500 shares at $4.58 ($2,290)
- 4 Open-market buy Chief Executive Officer bought 500 shares at $4.55 ($2,275)
- 4 Open-market buy Director bought 16,500 shares at $4.48 ($73,920)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $3.97 ($39,650)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $4.37 ($13,110)
- 4 Open-market buy Chief Financial Officer bought 300 shares at $4.10 ($1,230)
- 4 Open-market buy Chief Operating Officer bought 300 shares at $4.19 ($1,257)
Page 8 of 19 · 376 filings